Inhibition of both the ligand and receptor of the hepatocyte growth factor/c-MET pathway, in combination with chemotherapy, retards progression of PanIN lesions in KPC mice

Autor:	James W. Janetka, Minote Apte, Zhihong Xu, Jeremy S. Wilson, Vishnu C. Damalanka, David Goldstein, Chamini J. Perera, Sri Pothula, Lidija Klampfer, Matthew Mahoney, Tony C. Y. Pang, Alpha Raj Mekapogu, Z. Hosen, Ron Pirola
Rok vydání:	2020
Předmět:	Chemotherapy C-Met Hepatology business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastroenterology Ligand (biochemistry) chemistry.chemical_compound chemistry medicine Cancer research Hepatocyte growth factor Receptor business medicine.drug
Zdroj:	Pancreatology. 20:S39-S40
ISSN:	1424-3903
DOI:	10.1016/j.pan.2020.07.049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e4497a9ed07102a6245605911a7e84ec https://doi.org/10.1016/j.pan.2020.07.049 Zobrazit plný text záznamu Full Text from ScienceDirect